Moderna to submit emergency application for vaccine in US, Europe

World

Published: 2020-11-30 14:34

Last Updated: 2024-03-27 11:55


Moderna to submit emergency application for vaccine in US, Europe
Moderna to submit emergency application for vaccine in US, Europe

The American company Moderna announced that it will submit emergency licensing applications for its COVID-19 vaccine in the United States and Europe Monday, after the full results of clinical trials confirmed a 94.1 effectiveness rate.

According to the New York Times, if the application is approved, Americans could have the vaccine administered as early as Dec. 21.